Abstract
Tuberculosis occurred in humans probably as early as 8,000 bc in its sporadic form. Indeed, it is mentioned in India’s Vedas, the most sacred texts of Hinduism, and later by Hippocrates, Celse D’Aretée de Cappadoce (170 bc), and Avicene (Calmette 1923; Calmette et al. 1928). Recently, genetic studies of the tubercle bacillus have found its progenitor to come into existence possibly as early as 35,000 bc (Gutierrez et al. 2005). Tuberculosis became an epidemic problem once humans settled and crowded into permanent, food-producing social networks. Thus, Egyptian mummies from the Rhamses period (3,000 bc) showed spinal deformities consistent with tuberculosis – Pott’s disease. Hippocrates used the term “phthisis,” the Greek term for “consumption,” to describe the wasting away experienced by individuals with tuberculosis. Swollen cervical lymph nodes were known as “scrofula” or the “King’s Evil” in England (Artenstein et al. 1995). The belief that they could be healed by the King’s touch, although coincidentally true in some cases, likely had more to do with host immune responses than regal intervention.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Abou-Zeid CI, Smith J, Grange J et al (1986) Subdivision of daughter strains of Bacille Calmette-Guérin (BCG) according to secreted protein patterns. J Gen Microbiol 132:3047–3053
Aronson JD, Santoshan M, Comstock GW et al (2004) Long-term efficacy of BCG vaccine in American Indians and Alaska natives: a 60-year follow-up study. JAMA 291:2068–2091
Artenstein AW (2008) New generation smallpox vaccines: a review of preclinical and clinical data. Rev Med Virol 18(4):225–235
Artenstein AW, Kim JH, Williams WJ et al (1995) Isolated peripheral tuberculous lymphadenitis in adults: current clinical and diagnostic issues. Clin Infect Dis 20:876–882
Barklay WR, Buzey WM, Balgard DW et al (1973) Protection of monkeys against airborne tuberculosis by aerosol vaccination with bacillus Calmette-Guérin. Am Rev Respir Dis 107:351–358
Baumann S, Eddine AM, Kaufmann SHE (2006) Progress in tuberculosis vaccine development. Curr Opin Immunol 18:1–11
Behr MA, Small PM (1999) A historical and molecular phylogeny of BCG strains. Vaccine 17:915–922
Bernard JML (1931) Le drame de Lübeck. Bull Acad Nat Méd 106:673–682
Bloom BR, Fine PE (1994) The BCG experience: implication for future vaccines against tuberculosis. In: Bloom BR (ed) Tuberculosis: pathogenesis protection and control. ASM Press, Washington, DC
Bonah C (2005) The ‘experimental stable’ of the BCG vaccine: safety, efficacy, proof, and standards, 1921–1933. Stud Hist Phil Biol Biomed Sci 36:696–721
Brewer TF, Colditz GA (1995) Relationship between Bacille Calmette-Guérin (BCG) strains and the efficacy of BCG Vaccine in the prevention of tuberculosis. Clin Infect Dis 20:126–135
Brock TD (1999) Robert Koch: a life in medicine and bateriology. ASM Press, Washington, DC
Burke DS (1993) Of postulates and peccadilloes: Robert Koch and vaccine (tuberculin) therapy for tuberculosis. Vaccine 11(8):795–804
Bynum WF (1994) Science and the practice of medicine in the ninetheenth century. Cambridge University Press, New York
Calmette A (1923) Tubercle bacillus infection and tuberculosis in man and animals. Processes of infection and resistance. (trans: Smith GH, Soper WB). Williams and Wilkins Co, Baltimore
Calmette A, Bocquet A, Nègre L (1921) Contribution a l’étude du bacille tuberculeux bilié. Ann Inst Pasteur 9:561–570
Calmette A, Bocquet A, Nègre L (1926) Prémunition des nouveaux-nés contre la tuberculose par le vaccin BCG (1921–1926). Ann Institut Pasteur XL:89–120
Calmette A, Bocquet A, Nègre L (1928) L’infection bacillaire et la tuberculose chez l’homme et chez les animaux. In: Calmette A et al (eds) Vaccination préventive. Masson et Cie, Paris
Chung KT, Biggers CJ (2001) Albert Léon Charles Calmette (1863–1933) and the antituberculous BCG vaccination. Perspect Biol Med 44(3):349–389
Clemens JD, Jackie JH, Chuong JH et al (1983) The BCG controversy, methodological and statistical reappraisal. JAMA 249:2362–2369
Cohn ML, Davies CL, Middlebrook G (1958) Airborne immunization against tuberculosis. Science 128:1282–1283
Colditz GA, Brewer TF, Berkey CS et al (1994) Efficacy of BCG Vaccine in the prevention of tuberculosis: meta-analysis of the published literature. JAMA 271:698–702
Cole ST, Brosch R, Parkhill J et al (1998) Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature 395:537–544
Comstock GW (1964) Community research in tuberculosis Muscogee County Georgia. Public Health Rep 79:1045–1056
Comstock GW, Woolpert SF, Livesay VT et al (1976) Tuberculosis studies in Muscogee County, Georgia: twenty-year evaluation of a community trial of BCG vaccination. Public Health Rep 91:276–280
Corbel MJ, Fruth U, Griffiths E et al (2004) Report on WHO Consultation on the characterisation of BCG strains, Imperial College, London 15–16 December 2003. Vaccine 22(21–22):2675–2680
Daniel TM (2004) The impact of tuberculosis on civilization. Infect Dis Clin N Am 18:157–165
Daniel TM, Bates JH, Downes KA et al (1994) History of tuberculosis. In: Bloom BR (ed) Tuberculosis: pathogenesis, protection and control. ASM Press, Washington, DC
Dubos R, Dubos J (1952) Tuberculosis, man and society: the white plague. Little, Brown and Co, Boston
Dubos RJ, Pierce CH (1956) Differential characteristics in vitro and in vivo of several substrains of BCG. Am Rev Tuberc 74:655–717
Fomukong NG, Dale JW, Osborn TW et al (1992) Use of gene probes based on the insertion sequence IS986 differentiate between BCG vaccine strains. J Appl Bacteriol 72:126–133
Gelinas JA (1973) Albert Calmette. The Saigon years 1891–1893: a historical review. Mil Med 138(11):730–733
Gheorghiu M (1994) BCG induced mucosal immune responses. Int J Immunopharmacol 16:435–444
Gheorghiu M (1996) Antituberculosis BCG vaccine: lessons from the past. In: Plotkins S, Fantini B (eds) Vaccinia, vaccination and vaccinology: Jenner, Pasteur and their successors 87–94. Elsevier, Paris
Gheorghiu M, Lagrange PH (1983) Viability, heat stability and immunogenicity of four BCG vaccines prepared from four different BCG strain. Ann Immunol (Inst Pasteur) 134C:125–147
Gheorghiu M, Augier J, Lagrange PH et al (1983) Maintenance and control of the French BCG strain 1173 P2 (primary and secondary seed-lots). Bull Inst Pasteur 81:281–288
Gheorghiu M, Lagranderie M, Balazuc AM et al (1998) Cytotoxic activity induced by Mycobacterium bovis BCG. Dev Biol Stand Basel 92:199–208
Ginsberg AM (2002) What’s new in tuberculosis vaccines. Bull WHO 6:483–488
Grange JM, Biship PJ (1982) ‘Uber tuberkulose’. A tribute to Robert Koch’s discovery of the tubercle bacillus, 1882. Tubercle 63(1):3–17
Gros P, Skamene E, Forget A et al (1981) Genetic control of natural resistance to Mycobacterium bovis (BCG) in mice. J Immunol 127:2417–2421
Guérin C (1948) Le BCG et la prévention de la tuberculose. Rev Atomes 27:183–188
Gutierrez MC, Brosse S, Brosch R et al (2005) Ancient origin and gene mosaicism of the progenitor of Mycobacterium tuberculosis. PLoS Pathog 1(1):e5
Hawgood BJ (2007) Albert Calmette (1863–1933) and Camille Guérin (1872–1961): the C and G of BCG vaccine. J Med Biogr 15:139–146
Huygen K, Content J, Denis O et al (1996) Immunogenicity and protective efficacy of tuberculosis DNA vaccine. Nat Med 2:893–898
Kaufmann SHE, McMichael AJ (2005) Annulling a dangerous liaison: vaccination strategies against AIDS and tuberculosis. Nat Med Suppl 11(4):533–544
Koch R (1882) Die Ätiology der Tuberculose Berliner Klin. Wochenschrift 19:221–230
Laennec T (1928) Traité de l’auscultation médiate et de maladies du poumon et du coeur In: Calmette A, Boquet A, Nègre L (eds) L’Infection bacillaire et la tuberculose chez l’homme et chez les animaux. Masson et Cie, Paris
Lagranderie M, Frehel C, deChastellier C et al (1991) Cellular oxidative responses and mycobacterial growth inhibition in aerosol and intradermal BCG-immunized guinea-pigs. Biologicals 19:335–345
Lagranderie M, Ravisse P, Marchal G et al (1993) BCG induced protection in guinea-pigs vaccinated and challenged via the respiratory route. Tuber Lung Dis 74:38–46
Lagranderie M, Balazue AM, Gicquel B et al (1997) Oral immunization with recombinant Mycobacterium bovis BCG simian immunodeficiency virus nef induces local and systemic cytotoxic T-lymphocyte responses in mice. J Virol 71:2303–2309
Lange B (1931) Nouvelles recherches sur les causes des accidents de Lübeck. Rev Tuberc Extrait XII:1142–1170
Lotte A, Wasz-Hockert O, Poisson N et al (1984) BCG complications. Estimates of the risk among vaccinated subjects and statistical analysis of their main characteristics. Adv Tuberc Res 21:107–193
Minnikin DE, Minnikin SM, Dobson G et al (1983) Mycolic acid patterns of four vaccine strains of Mycobacterium bovis BCG. J Gen Microbiol 129:889–891
Mostowy S, Tsolaki AG, Small PM et al (2003) The in vitro, evolution of BCG vaccines. Vaccine 21:4270–4274
Murray JF (2004) Mycobacterium tuberculosis and the cause of consumption: from discovery to fact. Am J Respir Crit Care Med 169:1086–1088
Orme IM (2005) Current progress in Tuberculosis vaccine development. Vaccine 23(17–18):2105–2108
Orme IM (2006) Preclinical testing of new vaccines for tuberculosis. A comprehensive review. Vaccine 24:2–19
Orme JM, Collins FM (1984) Adoptive protection of the mycobacterium tuberculosis-infected lung: dissociation between cells that passively transfer protective immunity and those that transfer delayed-type hypersensitivity. Cell Immunol 84:113–120
Osborn TW (1983) Changes in BCG strains. Tubercle 64:1–13
Pasteur L (1880) de l’atténuation du virus du choléra des poules. CR Acad Sci 91:673–680
Pasteur L, Chamberland C, Roux E (1881) Le vaccin du charbon. CR Acad Sci 92:666–668
Pym AS, Brodin P, Brosch R et al (2002) Loss of RD1 contributed to the attenuation of live tuberculosis vaccines mycobacterium bovis BCG and mycobacterium microti. Mol Microbiol 46:709–717
Rosenthal SR (1980) Routes and methods of administration. In: Rosenthal SR (ed) BCG vaccine tuberculosis-cancer. PSG Publishing Co Inc, Littleton, MA
Sakula A (1983) BCG: who were Calmette and Guérin? Thorax 38:806–812
Sekhuis VM, Freudenstein H, Sirks JL et al (1977) Report on results of a collaborative assay of BCG vaccines organized by IABS. J Biol Standard 5:85–109
Smith D, Harding GE, Chan JK et al (1979) Potency of 10 BCG vaccines evaluated by their influence on bacillemic phase of experimental airborne tuberculosis in guinea-pigs. J Biol Standard 7:179–197
Société des Nations (CH745) (1928) Organisation d’hygiène rapport de la conférence technique pour l’étude de la vaccination antituberculeuse par le BCG. Institut Pasteur Paris-Genève
Springett VH, Sutherland J (1970) Comparison of the efficacy of liquid and freeze dried strains of BCG Vaccine in preventing tuberculosis. Br Med J 4:148–150
Stead WW (1996) Epidemiology of the global distribution of tuberculosis. In: Koprowski H, Oldstone MBA (eds) Microbe hunters: then and now. Medi-Ed Press, Bloomington, IL
ten Dam HG (1993) BCG vaccination In: Reichmann LB, Hershfield ES (eds) Tuberculosis: a comprehensive international approach, 1st edn. Marcel Dekker, New York
Wallgren A (1928) Intradermal vaccination with BCG virus. JAMA 91:1876–1881
Weil-Hallé B, Turpin R (1925) Premiers essais de vaccination antituberculeuse de l’enfant par le bacille de Calmette-Guérin (BCG). Bull et mém Soc méd Hôp 49:1589–1601
WHO (1997) EPI information system global summary. WHO/EPI/Gen/98.10
WHO (1979) Tuberculosis prevention trials: Madras. Trial of BCG vaccines in South India for tuberculosis prenvention. Bull WHO 57:819–827
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Gheorghiu, M., Lagranderie, M., Balazuc, AM. (2010). Tuberculosis and BCG. In: Artenstein, A. (eds) Vaccines: A Biography. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-1108-7_8
Download citation
DOI: https://doi.org/10.1007/978-1-4419-1108-7_8
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4419-1107-0
Online ISBN: 978-1-4419-1108-7
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)